Kymera Therapeutics Inc (KYMR) Insider Trading
- $64,580,508.56
- $131,553,155.40
- March 3, 2025
- Nello Mainolfi
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Aug. 4, 2021 | CEO | 1,037 | $60.03 | Sell | $62,251.11 | |
| Aug. 2, 2021 | CEO | 23,456 | $60.30 | Sell | $1,414,396.80 | |
| July 30, 2021 | CEO | 6,279 | $60.07 | Sell | $377,179.53 | |
| July 28, 2021 | CEO | 3,864 | $60.15 | Sell | $232,419.60 | |
| July 26, 2021 | CEO | 9,015 | $60.15 | Sell | $542,252.25 | |
| July 8, 2021 | CEO | 48,000 | $49.70 | Sell | $2,385,600.00 | |
| July 1, 2021 | Director | 544,166 | $47.00 | Buy | $25,575,802.00 | |
| June 9, 2021 | CEO | 5,752 | $50.02 | Sell | $287,715.04 | |
| June 7, 2021 | CEO | 12,724 | $50.14 | Sell | $637,981.36 | |
| June 3, 2021 | CFO | 10,000 | $46.87 | Sell | $468,700.00 | |
| May 12, 2021 | CEO | 8,245 | $50.05 | Sell | $412,662.25 | |
| April 26, 2021 | CEO | 2,768 | $40.18 | Sell | $111,218.24 | |
| April 23, 2021 | CEO | 680 | $40.01 | Sell | $27,206.80 | |
| April 19, 2021 | CEO | 653 | $40.00 | Sell | $26,120.00 | |
| April 15, 2021 | CEO | 4,940 | $40.29 | Sell | $199,032.60 | |
| April 12, 2021 | CEO | 15,267 | $32.62 | Sell | $498,009.54 | |
| April 9, 2021 | CEO | 22,794 | $33.68 | Sell | $767,701.92 | |
| March 15, 2021 | Insider | 10,305 | $60.17 | Sell | $620,051.85 | |
| March 15, 2021 | CFO | 8,195 | $60.17 | Sell | $493,093.15 | |
| March 12, 2021 | Director | 229,350 | $56.50 | Sell | $12,958,275.00 | |
| March 11, 2021 | Insider | 4,695 | $60.05 | Sell | $281,934.75 | |
| March 11, 2021 | CFO | 1,805 | $60.07 | Sell | $108,426.35 | |
| March 8, 2021 | CFO | 10,000 | $50.65 | Sell | $506,500.00 | |
| Feb. 19, 2021 | Insider | 8,887 | $55.09 | Sell | $489,584.83 | |
| Feb. 17, 2021 | Insider | 7,550 | $58.39 | Sell | $440,844.50 |
Insiders are both buying and selling Kymera Therapeutics Inc stock.
The insider traders at Kymera Therapeutics Inc are: Nello Mainolfi, Bruce Booth, Bvf Partners L P/Il, Bruce N Jacobs, Venture Fund X L.P. Atlas, Jared Gollob, Ellen Chiniara, Jeffrey W. Albers, Richard Chesworth, Joanna Horobin, Bruce N. Jacobs, Pamela Esposito, and Jeremy G Chadwick
The most active insider trader at Kymera Therapeutics Inc is Nello Mainolfi with 19 trades.
Bruce Booth has sold the most Kymera Therapeutics Inc stock with a total value of $95,968,097.55.
Bvf Partners L P/Il has bought the most Kymera Therapeutics Inc stock with a total value of $67,099,474.40.
The most recent insider trade for Kymera Therapeutics Inc was on March 3, 2025.
The single biggest insider buy for Kymera Therapeutics Inc was from Bvf Partners L P/Il with a total value of $25,575,802.00 on July 1, 2021.
The single biggest insider sell for Kymera Therapeutics Inc was from Bruce Booth with a total value of $17,345,811.60 on July 9, 2024.